| Application no. and date | 03704652.1 (espacenet) (Federated) (European Patent Register), 20030219 | | Patent/reg. no. and date | DK/EP 1478399, 20120321 | | Publication date | 20041124 | | Priority no. and date | DE 10207160, 20020220, EP 02003811, 20020220 | | EP pub. no. and date |
EP 1478399 20041124 | | Effective date | | | Applicant/owner | AstraZeneca AB,
SE 151 85 Södertälje, SE | | Applicant ref. no. | P49771DK01 | | Inventor | EISTETTER, Klaus, Säntisblick 7
78465 Konstanz, DE,
DIETRICH, Rango, Im Tiergarten 16
78465 Konstanz, DE,
NEY, Hartmut, Peter-Thumb-Str. 46
78464 Konstanz, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/166 (2006.01) , A61K 31/44 (2006.01) , A61K 45/06 (2006.01) , A61K 9/20 (2006.01) , A61P 11/06 (2006.01) | | Title | ORAL DOSISFORM INDEHOLDENDE EN PDE-4-INHIBITOR SOM EN AKTIV BESTANDDEL OG POLYVINYLPYRROLIDON SOM EXCIPIENS | | Int. application no. | EP2003001650 | | Int. publication no. | WO2003070279 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
